Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world.

We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

For 80 years, we have been keeping our promise in the UK to make life better. Lilly UK was our first business to open outside the US and we are proud to be one of a small number of pharmaceutical companies in the UK that not only discover, but also make and deliver medicines to patients.

At our core, we focus on discovery to make new medicines to help people live better lives. Discovering new medicines means never being satisfied with what we’ve achieved. It means pushing beyond what we have already learnt and then pushing again.

Lilly has a history of innovation. We were the first to manufacture commercial insulin and the polio vaccine and today, Lilly continues to develop innovative and life-saving treatments in disease areas suchas neurology, diabetes, diseases of the immune system and oncology. We have a very strong pipeline with over 60 potential new medicines being researched and hope to launch at least 20 new medicines in the 10 years from 2014 to 2023.

Erl Wood (in Surrey) is Lilly’s largest Research and Development (R&D) site outside the US where our leading scientists focus on neuroscience research, to find new treatments for Alzheimer’s disease, Parkinson’s disease, depression and chronic pain. We have a strong publication record and a high profile at major scientific meetings and we are proud to have received notable accolades including our Prix Galien Award for olanzapine and Queens Award for innovation in the UK.

In the last 10 years, we have spent over £1.1 billion on research in the UK and invested more than £85 million in our UK R&D facilities, so we can continue to discover the medicines of the future.

At Lilly, we are more than our medicines, we are people who are inspired and unified to make life better for people around the world.

To learn more about Lilly, please visit us at www.lilly.co.uk.

Lilly scientists work in collaboration with academic institutions and research organisations around the world in seeking to understand disease mechanisms.  Supporting the North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics is one of many ways we collaborate and we believe this CPT programme can help address a critical skills shortage by helping train the next generation of clinical pharmacologists.  We provide students with the opportunity to find out for themselves what it’s like to work in the pharmaceutical industry; students spend three to twelve months at one of our research sites, with the opportunity to contribute to national and international research programmes.

Back to: North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics